文献速递细胞病理与分子病理神经与头颈病理

高危HPV PCR检测在细胞形态不确定的头颈部FNA标本中的诊断价值

Diagnostic utility of high-risk HPV polymerase chain reaction-based testing in head and neck FNA specimens with indeterminate cytomorphology.
PubMed 文献 · Cancer Cytopathol · 2026-01-01

该研究回顾性分析了279例头颈部FNA标本的液基细胞学残留材料行高危HPV PCR检测,发现细胞学 indeterminate 标本中HPV PCR阳性对组织学确诊鳞状细胞癌的阳性预测值为100%(95%CI 78.5%-100.0%),支持将HPV PCR纳入常规细胞学解读以升级部分不确定标本。

要点

  • 细胞学不确定的头颈部FNA标本中,HPV PCR阳性预测鳞癌的PPV为100%。
  • HPV PCR阳性可辅助将部分细胞学不确定标本升级为恶性。
  • 建议将高危HPV PCR整合入头颈部FNA的常规细胞学评估。

核心结论

  • 细胞学不确定的头颈部FNA液基标本中,高危HPV PCR阳性对恶性肿瘤的阳性预测值为100%(95%CI 78.5%-100.0%)。

研究设计与样本

  • 回顾性研究,纳入5年内279例有配对高危HPV PCR检测的头颈部FNA标本。

主要发现

  • HPV PCR结果阳性占50.2%,阴性占40.9%,不确定占9.0%。
  • HPV阳性率从细胞学阴性标本的0%到阳性标本的57.3%,非典型、可疑、无诊断分别为19.0%、41.2%、50.0%。
  • 细胞学不确定且HPV PCR阳性的标本(n=14)阳性预测值为100%(95%CI 78.5%-100.0%)。
  • 盲法阅片发现15例细胞学阳性标本的恶性判读很大程度上依赖HPV阳性,均经证实为鳞状细胞癌。

临床怎么用

  • 对细胞形态不确定的头颈部FNA液基标本,可结合高危HPV PCR结果辅助恶性判读。
  • HPV PCR阳性有可能将部分不确定标本升级为恶性,加速确定性治疗并避免额外有创取样。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fine-needle aspiration (FNA) is critical in the initial diagnosis of many high-risk human papillomavirus (HR-HPV)-associated, metastatic oropharyngeal squamous cell carcinomas. Updated guidelines recommend HR-HPV-specific polymerase chain reaction (PCR) analysis over p16 immunohistochemistry on FNA specimens because p16 performs poorly on cytology material. PCR-based assays on liquid cytology material have demonstrated excellent analytic performance; however, the diagnostic utility of a positive HR-HPV PCR result in specimens with indeterminate cytomorphology remains uncharacterized. METHODS: The authors retrospectively identified 279 head and neck FNA specimens that had paired HR-HPV PCR testing on residual liquid cytology material over a 5-year period. The positive predictive value for histopathologically confirmed squamous cell carcinoma on surgical follow-up was calculated within each cytologic interpretive category. RESULTS: The HR-HPV PCR results were positive in 50.2% of specimens, negative in 40.9%, and indeterminate in 9.0%. The HR-HPV positivity rate ranged from 0% in specimens categorized as negative for malignancy to 57.3% in cytologically positive specimens, with 19.0%, 41.2%, and 50.0% positivity in the atypical, suspicious, and nondiagnostic categories, respectively. Among cytologically indeterminate specimens with positive HR-HPV PCR results (n = 14), the positive predictive value was 100% (95% confidence interval, 78.5%-100.0%). Blinded slide review additionally identified 15 cytologically positive specimens in which the definitive malignant interpretation depended substantially on HR-HPV positivity; all 15 were confirmed as squamous cell carcinoma. CONCLUSIONS: A positive HR-HPV PCR result on liquid cytology material carries a positive predictive value of 100% for malignancy in cytologically indeterminate head and neck FNA specimens. These findings support integrating HR-HPV PCR analysis into routine cytologic interpretation with the potential to upgrade some indeterminate specimens to malignant when HR-HPV is detected, expediting definitive treatment and sparing patients additional, invasive sampling.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Torous VF, Faquin WC. Diagnostic utility of high-risk HPV polymerase chain reaction-based testing in head and neck FNA specimens with indeterminate cytomorphology. Cancer Cytopathol. 2026. PMID: 42622106. doi:10.1002/cncy.70144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。